| carbidopa/levodopa / Generic mfg. |
NCT00139867: A Multicenter, Open-label Trial to Assess Subject Preference of PARCOPA, Carbidopa/Levodopa Orally Disintegrating Tablets, Compared to Conventional Carbidopa/Levodopa Tablets in Subjects With Stable Parkinson's Disease |
|
|
| Completed | 3 | | US | PARCOPA | UCB Pharma | Parkinson's Disease | 05/04 | 05/04 | | |
NCT00203164: Study to Evaluate the Safety and Tolerability of Rasagiline in Advanced Parkinson's Disease Patients |
|
|
| Completed | 3 | 254 | US | rasagiline mesylate | Teva Branded Pharmaceutical Products R&D, Inc. | Parkinson's Disease | 07/05 | 09/06 | | |
NCT00139880: A Single Center, Randomized, Double-blind, Crossover Pilot Trial Comparing the Onset of Action of Parcopa™ With Sinemet® in Subjects With Stable Parkinson's Disease |
|
|
| Completed | 3 | | US | Parcopa | UCB Pharma | Parkinson's Disease | 08/05 | 08/05 | | |
NCT00203177: Rasagiline in Advanced Parkinson's Disease Patients With Motor Fluctuations Treated With Levodopa/Carbidopa Therapy. |
|
|
| Completed | 3 | 254 | US, Canada | rasagiline mesylate, rasagiline mesylate 1.0 mg | Teva Branded Pharmaceutical Products R&D, Inc. | Parkinson's Disease | 12/06 | | | |
| Completed | 3 | 139 | US | Levodopa/Carbidopa, Placebo, Patching | Jaeb Center for Health Research, National Eye Institute (NEI) | Amblyopia | 01/14 | 04/14 | | |
NCT04000919: Effects of 5HTP and LDOPA on CNS Excitability After SCI |
|
|
| Suspended | 2/3 | 30 | US | 5HTP, carbidopa, L-DOPA, Sinemet, Carbidopa, Placebo oral tablet | Jessica M D'Amico | Spinal Cord Injuries | 06/23 | 12/23 | | |
| Recruiting | 2/3 | 60 | RoW | levodopa-carbidopa, Montelukast | Mostafa Bahaa | Parkinson Disease | 11/24 | 12/25 | | |
